Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganaxolone for Smoking Cessation
NCT01857531Phase 2Completed
- Start
- Jun 2013
- Primary completion
- Jul 2013
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of ganaxolone in nicotine dependence. Started Jun 2013; status: completed.
02
Drugs
ganaxolone
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01857531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01857531.